A detailed history of Tower View Investment Management & Research LLC transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Tower View Investment Management & Research LLC holds 5,566 shares of DRTS stock, worth $17,143. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,566
Previous 5,566 -0.0%
Holding current value
$17,143
Previous $14,000 7.14%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 15, 2022

BUY
$0.65 - $11.0 $3,617 - $61,226
5,566 New
5,566 $33,000

Others Institutions Holding DRTS

About Alpha Tau Medical Ltd.


  • Ticker DRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,011,296
  • Market Cap $213M
  • Description
  • Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...
More about DRTS
Track This Portfolio

Track Tower View Investment Management & Research LLC Portfolio

Follow Tower View Investment Management & Research LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower View Investment Management & Research LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tower View Investment Management & Research LLC with notifications on news.